Cerus Corp (CERS)
1.76
-0.05
(-2.76%)
USD |
NASDAQ |
Nov 07, 16:00
1.78
+0.02
(+1.14%)
After-Hours: 20:00
Cerus Revenue (TTM): 176.23M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 176.23M |
| June 30, 2024 | 169.98M |
| March 31, 2024 | 163.76M |
| December 31, 2023 | 156.37M |
| September 30, 2023 | 153.63M |
| June 30, 2023 | 153.43M |
| March 31, 2023 | 155.58M |
| December 31, 2022 | 162.05M |
| September 30, 2022 | 157.88M |
| June 30, 2022 | 154.44M |
| March 31, 2022 | 144.92M |
| December 31, 2021 | 130.86M |
| September 30, 2021 | 119.19M |
| June 30, 2021 | 106.67M |
| March 31, 2021 | 96.69M |
| December 31, 2020 | 91.92M |
| September 30, 2020 | 84.64M |
| June 30, 2020 | 79.05M |
| March 31, 2020 | 75.76M |
| December 31, 2019 | 74.65M |
| September 30, 2019 | 70.26M |
| June 30, 2019 | 67.64M |
| March 31, 2019 | 64.85M |
| December 31, 2018 | 60.91M |
| September 30, 2018 | 60.62M |
| Date | Value |
|---|---|
| June 30, 2018 | 56.02M |
| March 31, 2018 | 50.13M |
| December 31, 2017 | 43.57M |
| September 30, 2017 | 37.45M |
| June 30, 2017 | 36.83M |
| March 31, 2017 | 36.56M |
| December 31, 2016 | 37.18M |
| September 30, 2016 | 36.71M |
| June 30, 2016 | 34.58M |
| March 31, 2016 | 34.16M |
| December 31, 2015 | 34.22M |
| September 30, 2015 | 34.15M |
| June 30, 2015 | 36.47M |
| March 31, 2015 | 36.24M |
| December 31, 2014 | 36.42M |
| September 30, 2014 | 36.06M |
| June 30, 2014 | 36.24M |
| March 31, 2014 | 37.79M |
| December 31, 2013 | 39.66M |
| September 30, 2013 | 40.95M |
| June 30, 2013 | 38.66M |
| March 31, 2013 | 37.74M |
| December 31, 2012 | 36.70M |
| September 30, 2012 | 34.15M |
| June 30, 2012 | 35.14M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
74.65M
Minimum
Dec 2019
176.23M
Maximum
Sep 2024
130.38M
Average
149.18M
Median
Revenue (TTM) Benchmarks
| Haemonetics Corp | 1.334B |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 38.25M |
| Xtant Medical Holdings Inc | 110.94M |
| Catheter Precision Inc | 0.436M |